Blue Heron Biotechnology has developed a scalable, automated manufacturing platform that industrializes the process of gene synthesis.  GeneMaker® is an automated, high throughput gene synthesis platform that synthesizes very long genes and DNA sequences economically and with perfect accuracy.  This proprietary platform allows the Company to synthesize any gene, any gene variant or any DNA sequence.  As an early entrant and now with years of experience making thousands of perfectly accurate genes, BHBT has emerged as the leader in the rapidly growing gene synthesis market, providing the broadest range of synthetic DNA sequences and related services to thousands of researchers across multiple industries, including 19 of the top 20 pharmaceutical and biotechnology companies.

TASCF participated in the Series A round and TAAF participated in the Series C and D rounds.